Liver Forum 13

E-mail Print
The Liver Forum 13 was held in Paris, France on September 7, 2022 

Materials

pdfAgenda

pdfParticipant List.pdf

Session I: Welcome & Introduction to Liver Forum 13

pdfLiver Forum Updates, PSC Forum, Pediatric Cholestatic Program, RWD-E Program, Placebo Database
Veronica Miller, Forum for Collaborative Research

pdfHistology Webinar Series
Melissa Palmer, Liver Consulting LLC

pdfCirrhosis Manuscript
Mazen Noureddin, Houston Methodist Hospital and Houston Research Institute

Session II: NIT and Clinical Outcomes

pdfRecap from Liver Forum 12 (Apr 22)
Veronica Miller, Forum for Collaborative Research

pdfLessons from the Madrigal Program
Becky Taub, Madrigal Pharmaceuticals

pdfNew Data from ILC
Jörn Schattenberg, University Medical Center Mainz

Session III: Competing Risks in Trial Analysis 

pdfBrief Overview of Issues
Kris Kowdley, Liver Institute Northwest
Frank Anania, U.S. Food and Drug Administration

Session IV: Anticipating New Science: Disentangling Fibrosis

pdfBiochemistry
Morten Karsdal, Nordic Bioscience

pdfHistology/AI
Arun Sanyal, Virginia Commonwealth University

Session V: New Working Groups Discussion

pdfPooling of Data and Monotherapy Arms
Sharat Varma, Novo Nordisk

pdfMonotherapy Arms
Michelle Long, Novo Nordisk

pdfDigital/AI/ML Histology
Nikolai V. Naoumov, Independent Expert

pdfPlacebo Arm Database
Manal Abdelmalek, Mayo Clinic
Michael Cooreman, Inventiva Pharma